UPDATE : Friday, February 16, 2018
상단여백
Domestic vaccine development for norovirus remains stagnant
Domestic vaccine research and development (R&D) on norovirus remains sluggi...
by Lee Han-soo  |  2018-02-15 08:05
라인
LSK Global PS eyes global clinical research market
South Korea is one of the most advanced countries regarding clinical resear...
by Lee Hye-seon  |  2018-02-15 08:02
라인
Medytox in final stage to sell facial filler in China
Medytox’ entry into the Chinese anti-wrinkle injections market with its sel...
by So Jae-hyeon  |  2018-02-14 11:37
라인
Yuyu to pay cash dividend to shareholders
Yuyu Pharmaceuticals said Tuesday that it has decided to pay a cash dividen...
by Lee Han-soo  |  2018-02-13 17:50
라인
Eli Lilly Korea sees chances of reimbursement for stomach cancer drug
Eli Lilly and Company said it expects to get insurance coverage for its sto...
by Marian Chu  |  2018-02-13 17:49
라인
‘Novo Nordisk Korea has no plan to downsize’
Multinational pharmaceutical companies have recently struggled over labor d...
by Nam Doo-hyun  |  2018-02-13 15:46
라인
CTC Bio gets sales approval for erectile dysfunction treatment in Paraguay
CTC Bio said Tuseday that it has acquired sales approval for its erectile d...
by Lee Han-soo  |  2018-02-13 13:44
라인
Huons posts record sales
Huons said Monday its sales hit a record high of 278 billion won ($256.1 mi...
by Lee Han-soo  |  2018-02-13 11:24
라인
SK, Sanofi strike $155-mil licensing agreement for vaccine tech
SK Chemicals said Monday it would export independently developed cell-cultu...
by Marian Chu  |  2018-02-12 18:02
라인
Safer, more potent new drugs coming up this year
Multinational pharmaceutical giants are getting ready to release new drugs ...
by Nam Doo-hyun  |  2018-02-12 15:54
라인
4 foreign companies win go-ahead to launch clinical trials in Korea
The Ministry of Food and Drug Safety (MFDS) Friday gave regulatory approval...
by Marian Chu  |  2018-02-12 13:06
라인
‘New combo may become standard soft tissue sarcoma treatment’
With Lilly Korea’s Lartruvo (ingredient: olaratumab) obtaining insurance be...
by Nam Doo-hyun  |  2018-02-09 15:50
라인
Takeda announces efficacy of hypertension treatment in Korean patients
Takeda Pharmaceuticals Korea said Friday it published new phase 3 trial dat...
by Marian Chu  |  2018-02-09 12:18
라인
MSD Korea’s Keytruda gets 3 new indications as drug sales skyrocket
MSD Korea said Thursday that its revenue-driving anti-PD-1 immunotherapy Ke...
by Marian Chu  |  2018-02-08 17:33
라인
Dementia treatments in active R&D with government support
With the government promising to spend 1 trillion won ($920 million) budget...
by So Jae-hyeon  |  2018-02-08 16:10
라인
NIH transfers tech to make hand-foot-mouth disease vaccine
The National Institute of Health (NIH) said it has signed an agreement with...
by Lee Han-soo  |  2018-02-08 11:39
라인
‘Allergan Korea aims for 100 billion won in sales this year’
Allergan Korea said it led the domestic medical aesthetic market with doubl...
by Marian Chu  |  2018-02-07 18:08
라인
Dong-A ST sales decrease year-on-year
Dong-A ST said Wednesday that its sales slightly fell to 555.1 billion won ...
by Lee Han-soo  |  2018-02-07 18:08
라인
Sanofi to conduct P3 clinical trials for Hanmi’s diabetic treatment
Sanofi announced Wednesday that it plans to conduct two phase 3 clinical tr...
by Lee Han-soo  |  2018-02-07 17:13
라인
Is Dong-A shifting focus to generic drugs?
The pharmaceutical industry is paying attention to why Dong-A Pharmaceutica...
by Lee Hye-seon  |  2018-02-07 14:26
여백
여백
여백
Back to Top